JP2024531188A5 - - Google Patents
Info
- Publication number
- JP2024531188A5 JP2024531188A5 JP2024508384A JP2024508384A JP2024531188A5 JP 2024531188 A5 JP2024531188 A5 JP 2024531188A5 JP 2024508384 A JP2024508384 A JP 2024508384A JP 2024508384 A JP2024508384 A JP 2024508384A JP 2024531188 A5 JP2024531188 A5 JP 2024531188A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutically acceptable
- acceptable salt
- use according
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163232107P | 2021-08-11 | 2021-08-11 | |
| US63/232,107 | 2021-08-11 | ||
| PCT/US2022/040115 WO2023018904A1 (en) | 2021-08-11 | 2022-08-11 | Treatment of hair loss disorders with deuterated jak inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024531188A JP2024531188A (ja) | 2024-08-29 |
| JP2024531188A5 true JP2024531188A5 (cg-RX-API-DMAC7.html) | 2025-10-15 |
Family
ID=83151848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024508384A Pending JP2024531188A (ja) | 2021-08-11 | 2022-08-11 | 重水素化jak阻害剤による脱毛障害の治療 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US12285432B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4384175A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024531188A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118159272A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022328272A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3228505A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023018904A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10561659B2 (en) * | 2016-05-04 | 2020-02-18 | Concert Pharmaceuticals, Inc. | Treatment of hair loss disorders with deuterated JAK inhibitors |
| US20230390292A1 (en) * | 2020-10-28 | 2023-12-07 | Sun Pharmaceutical Industries, Inc. | Regimens for the treatment of hair loss disorders with deuterated jak inhibitors |
| WO2023018904A1 (en) | 2021-08-11 | 2023-02-16 | Concert Pharmaceuticals, Inc. | Treatment of hair loss disorders with deuterated jak inhibitors |
| US12364699B2 (en) | 2023-10-10 | 2025-07-22 | Sun Pharmaceuticals Industries, Inc. | Method of treating hair loss disorders |
| US20260027120A1 (en) * | 2024-07-25 | 2026-01-29 | Sun Pharmaceutical Industries, Inc. | Methods of treatment of jak inhibition responsive conditions with deuterated jak inhibitors |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9925962D0 (en) | 1999-11-02 | 1999-12-29 | Novartis Ag | Organic compounds |
| CZ20033211A3 (cs) | 2001-05-03 | 2004-09-15 | F. Hoffmann-La Roche Ag | Farmaceutická léková forma amorfního nelfinavir mesylátu |
| WO2006039237A1 (en) | 2004-09-29 | 2006-04-13 | Cordis Corporation | Pharmaceutical dosage forms of stable amorphous rapamycin like compounds |
| WO2007065167A1 (en) * | 2005-12-02 | 2007-06-07 | The Johns Hopkins University | Use of high-dose oxazaphosphorine drugs for treating immune disorders |
| HUE028588T2 (hu) | 2005-12-13 | 2016-12-28 | Incyte Holdings Corp | Heteroaril-szubsztituált pirrolo[2,3-b]piridinek és pirrolo[2,3-b]pirimidinek mint Janus-kináz inhibitorok |
| LT1993360T (lt) | 2005-12-28 | 2017-06-12 | Vertex Pharmaceuticals Incorporated | N-[2,4-bis(1,1-dimetiletil)-5-hidroksifenil]-1,4-dihidro-4-oksochinolin-3-karboksamido kieta forma |
| CL2008001709A1 (es) | 2007-06-13 | 2008-11-03 | Incyte Corp | Compuestos derivados de pirrolo [2,3-b]pirimidina, moduladores de quinasas jak; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, psoriasis, artritis reumatoide, entre otras. |
| WO2010083283A2 (en) | 2009-01-15 | 2010-07-22 | Incyte Corporation | Processes for preparing jak inhibitors and related intermediate compounds |
| PT2635299T (pt) | 2010-11-02 | 2019-10-14 | Univ Columbia | Métodos de tratamento de distúrbios de perda de cabelo |
| US9198911B2 (en) | 2010-11-02 | 2015-12-01 | The Trustees Of Columbia University In The City Of New York | Methods for treating hair loss disorders |
| DK2830662T3 (da) | 2012-03-29 | 2019-01-02 | Univ Columbia | Fremgangsmåder til behandlng af hårtabsforstyrrelser |
| EP3450434B1 (en) | 2012-06-15 | 2021-02-24 | CoNCERT Pharmaceuticals, Inc. | Deuterated derivatives of ruxolitinib |
| KR102242077B1 (ko) | 2012-11-15 | 2021-04-20 | 인사이트 홀딩스 코포레이션 | 룩솔리티니브의 서방성 제형 |
| MX2016010213A (es) | 2014-02-07 | 2017-04-13 | Auspex Pharmaceuticals Inc | Formulaciones farmaceuticas novedosas. |
| US10561659B2 (en) * | 2016-05-04 | 2020-02-18 | Concert Pharmaceuticals, Inc. | Treatment of hair loss disorders with deuterated JAK inhibitors |
| EP3921318A1 (en) | 2019-02-06 | 2021-12-15 | Concert Pharmaceuticals Inc. | Process for preparing enantiomerically enriched jak inhibitors |
| WO2023018904A1 (en) | 2021-08-11 | 2023-02-16 | Concert Pharmaceuticals, Inc. | Treatment of hair loss disorders with deuterated jak inhibitors |
-
2022
- 2022-08-11 WO PCT/US2022/040115 patent/WO2023018904A1/en not_active Ceased
- 2022-08-11 CA CA3228505A patent/CA3228505A1/en active Pending
- 2022-08-11 AU AU2022328272A patent/AU2022328272A1/en active Pending
- 2022-08-11 JP JP2024508384A patent/JP2024531188A/ja active Pending
- 2022-08-11 CN CN202280068208.XA patent/CN118159272A/zh active Pending
- 2022-08-11 EP EP22762213.1A patent/EP4384175A1/en active Pending
-
2023
- 2023-10-20 US US18/382,307 patent/US12285432B2/en active Active
-
2025
- 2025-03-24 US US19/088,476 patent/US20250275979A1/en active Pending